Advertisement

Topics

Boehringer Ingelheim Animal Health Company Profile

06:25 EST 23rd November 2017 | BioPortfolio

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 138 affiliates in 47 countries and approximately 41,300 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.


News Articles [1098 Associated News Articles listed on BioPortfolio]

Boehringer Ingelheim achieves good growth in the first half of 2017

Boehringer Ingelheim has delivered positive results for the first half of 2017. Net sales increased by 24 per cent on the same period in the previous year to 9.2 billion euros after adjustment for cur...

Boehringer Ingelheim: Is Animal Health the sweet spot of the industry?

Dr Joachim Hasenmaier, corporate board divisions, Animal Health and Consumer Healthcare, discusses BI’s transformational swap with Sanofi, which has seen them acquire Sanofi’s Animal Health Divisi...

Boehringer Ingelheim Enters the Clinic with Two New Diabetes Drugs

Boehringer Ingelheim starts two new Phase I trials with drugs intended to treat type 2 diabetes and obesity discovered through a partnership with Danish biotech Zealand.  The new Phase I trials initi...

Boehringer Ingelheim mit gutem Wachstum im ersten Halbjahr 2017

Ingelheim (ots) - - Querverweis: Bildmaterial wird über obs versandt und ist abrufbar unter http://www.presseportal.de/bilder - Boehringer Ingelheim zieht eine positive Bilanz nach dem ersten Halbj.....

GreaterGood.org Partners with Boehringer Ingelheim to Provide Medical Attention to Pets Rescued from Houston Floods

Nonprofit Organizations Provide Cash Grants, Vaccines and Medicine GreaterGood.org, an independent 501(c)(3) charitable organization devoted to improving the health and...

Dedicated to research for animals.

Dr Joachim Hasenmaier, Corporate Board Divisions Animal Health and Consumer Healthcare at Boehringer Ingelheim

Boehringer Ingelheim initiates phase IIa study of liver disease NASH compound

Boehringer Ingelheim and pharmaceutical company Pharmaxis announce that Boehringer Ingelheim has initiated a European and North American phase IIa trial in NASH with BI 1467335 (formerly known as PX...

Boehringer Ingelheim expands collaboration with Sarah Cannon Research Institute

Boehringer Ingelheim and Sarah Cannon Research Institute announced an expansion of their strategic partnership to bring innovative treatments to cancer patients by developing novel immuno-oncology the...

PubMed Articles [4509 Associated PubMed Articles listed on BioPortfolio]

Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study.

The interleukin-23 pathway is implicated genetically and biologically in the pathogenesis of Crohn's disease. We aimed to assess the efficacy and safety of risankizumab (BI 655066, Boehringer Ingelhei...

Participatory evaluation of delivery of animal health care services by community animal health workers in Karamoja region of Uganda.

An evaluation exercise was carried out to assess the performance of Community Animal Health Workers (CAHWs) in the delivery of animal health care services in Karamoja region, identify capacity gaps an...

Where to next with animal health in Latin America? The transition from endemic to disease-free status.

The Latin American and Caribbean region (LAC) is a leading global producer and exporter of animal products. Its livestock production systems are diverse, ranging from large-scale commercial enterprise...

The benefits of bursaries.

As a vet student, Michelle Townley benefited from a student research bursary awarded by MSD Animal Health. The experiences she gained through her research helped her in clinical practice. She now work...

Grasslands: a source of secondary metabolites for livestock health.

Grassland constitutes a huge reservoir of secondary metabolites (e.g., phenolic compounds, alkaloids, saponins, terpenoids, carotenoids, and quinones). This phytococktail may positively and/or negativ...

Clinical Trials [3071 Associated Clinical Trials listed on BioPortfolio]

Relative Bioavailability Study Between Two Formulations Containing Ambroxol Hydrochloride

to evaluate the bioavailability of ambroxol hydrochloride soft pastilles (test formulation), manufactured by Bolder Arzneimittel GmbH & Co. KG to Boehringer Ingelheim compared to ambroxol ...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fed Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Bioequivalency Study of Meloxicam Tablets Under Fasting Conditions

The objective of this study was the bioequivalence of a Roxane Laboratories' Meloxicam tablets, 15 mg, to Mobic® Tablets, 15 mg (Boehringer Ingelheim) under fasting conditions using a sin...

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fasting Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Companies [2272 Associated Companies listed on BioPortfolio]

Boehringer Ingelheim Pharmaceuticals, Inc

Boehringer Ingelheim Corporation is the U.S. member of the Boehringer Ingelheim worldwide group of companies dedicated to the discovery, development, manufacture and marketing of innovative human and ...

Boehringer Ingelheim Vetmedica, Inc

Boehringer Ingelheim Vetmedica, Inc., a subsidiary of Boehringer Ingelheim Corporation since 1981, is headquartered in St. Joseph, MO. From four sites, St. Joseph, MO; Elwood, KS; Sioux Center, IA; an...

Boehringer Ingelheim Animal Health

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 138 affiliates in 47 countries and approximatel...

Boehringer Ingelheim Pharmaceuticals, Inc.

Metabolism is one of Boehringer Ingelheim's core R&D areas and diabetes is one of the indications at the center of interest within the company's global research network. Boehringer Ingelheim is commit...

Boehringer Ingelheim Limited

The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally with 146...

More Information about "Boehringer Ingelheim Animal Health" on BioPortfolio

We have published hundreds of Boehringer Ingelheim Animal Health news stories on BioPortfolio along with dozens of Boehringer Ingelheim Animal Health Clinical Trials and PubMed Articles about Boehringer Ingelheim Animal Health for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Boehringer Ingelheim Animal Health Companies in our database. You can also find out about relevant Boehringer Ingelheim Animal Health Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record